Dr Rosenberg

Dr. Mark Rosenberg received his doctorate from Georgetown University School of Medicine in 1988 and has been involved with drug research since 1991.

With numerous certifications in several different fields of medicine, psychology and fitness, Dr. Rosenberg has a wide breadth of experience in both the public and private sector with particular expertise in the mechanisms of cancer treatment failure.

Dr. Rosenberg is an innovator, constantly developing new ideas, techniques, and drugs, to combat incurable diseases. Many countries outside of the U.S. allow novel drugs that have not gone through FDA trials to be administered to terminally ill patients with no other options. Taking advantage of this option, Dr. Rosenberg intermittently travels outside of the country where he treats individuals who are considered end-stage.

Curriculum Vitae for Mark Rosenberg, MD, FACEP


  • July 1990 – July 1993 Emergency Medicine Residency Brooke Army Medical Center Dept. of Emergency Medicine San Antonio, TX
  • July 1988 – July 1989 Transitional Internship Fitzsimons Army Medical Center Aurora, CO
  • July 1984 – May 1988 Doctor of Medicine Georgetown University School of Medicine Washington, DC
  • July 1982 – June 1983 Master of Science in Physiology Georgetown University Graduate School Washington, DC
  • Sept 1978 – May 1982 Bachelor of Arts in Biology University of Pennsylvania Philadelphia, PA

Committees/Advisory Board

  • 2011 - Present; Medical Advisor to Life Length Telomere Analysis Technology
  • 2003 - 2005; Chairman of Pharmacy and Therapeutics Committee, Bethesda Memorial Hospital
  • 2003 - 2005; Institutional Review Board, Bethesda Memorial Hospital
  • 2003 - Present; Consultant to the National Strength and Conditioning Assoc.
  • 2000 - 2005; Emergency Department Committee, Bethesda Memorial Hospital
  • 1999 - Present; Medical Advisor to Fitness Institute International
  • 1990 - Present; American College of Emergency Physicians


  • 2009; Board Certified, American Academy of Anti-aging Medicine
  • 2001; Diplomate of the American Academy of Anti-aging Medicine
  • 1996; Fellow of the American College of Emergency Physicians
  • 1994; Board-Certified by the American Board of Emergency Medicine
  • 1989; Diplomate of the National Board of Medical Examiners
  • 1989-1999; ATLS Provider and Instructor, American College of Surgeons
  • 1990-1992; PALS Provider, American Academy of Pediatrics
  • 1988-Present; ACLS Provider, American Heart Association
  • 1998; Certified Hypnotherapist, National Guild of Hypnotists
  • 1998; Certified Personal Trainer, National Strength and Conditioning Assoc.


  • 1989; US Army Certificate of Achievement Award, for performance above and beyond the call of duty during the tornado disaster in Alabama
  • 1989; US Army Commendation Medal
  • 1993; Award for Outstanding Senior Resident and Teacher
  • 1999; Valedictorian and Distinguished Speaker, Fitness Institute International
  • 1999; Cover of the monthly journal, "The Florida Hypnotist"


  • Epstein A, Zhang D, Schultz J, Rosenberg M, Kupcha P, Stellar E: The Failure of Ventricular Sodium to Control Sodium Appetite in the Rat; Journal of Physiology and Behavior. 32:683-686, 1984
  • Rosenberg, Mark A: Toxndex, Toxicological Emergency Reference Manual; Delray Beach, FL, MQ INC, 1991

Research Experience

  • Patent Pending in the U.S., Canada, and the European Union - CCK based oral appetite suppressant for the treatment of obesity, filed February 23, 2007
  • Development of "Cancer Cocktail"; U.S. Application Serial No. 13/464,896
    Title: Cytotoxic Therapy By Proton Flux Modulation
    Date Filed: May 4, 2012
  • IND status granted Feb 24, 2007 for use of angiotensin II to
    improve tumor blood flow during administration of cytotoxic cancer therapy
  • 2007- Wake Forest University; Inhibition of tumor growth in mice through glycolytic inhibition
  • 2009 - University of Miami; Inhibition of cancer growth (in vitro) through inhibition of proton pump and monocarboxylate transporters

Professional Experience

  • 2012 – Present; Medical Director; AML Diagnostics
  • 2012 – Present; Board of Directors; American Academy of Anti-aging medicine
  • 2011 – Present; Medical Advisor to Life Length Telomere Analysis Technology
  • 2010 – 2012; Medical Director, Age Diagnostic Laboratories
  • 2009 – Present; Program Director; Integrative Cancer fellowship
  • 2008 – Present; Chief Medical Officer; Rose Pharmaceuticals
  • 2006 – Present; Chief Science Officer and Director of research and Development; Vitalmax Vitamins
  • 2003 – Present; President and Medical Director The Institute for Healthy Aging, Delray Beach, FL
  • 2003 – 2004; Chief Science Officer and Director of Research and Development, “Nutrophy”, Miami, FL
  • 1999 – 2005; Assistant Director of Emergency Medicine, Bethesda Memorial Hospital, Boynton Beach, FL
  • 1996 – 1999; Associate Director of Emergency Medicine and Director of Quality Improvement, Westside Regional Medical Center, Plantation, FL
  • 1993 – 1996; Assistant Chief of Emergency Medicine; Consultant for Poisons and Overdoses; Director of Quality Improvement Walter Reed Army Medical Center, Washington, DC
  • 1995 – 1996; Staff Emergency Physician, Shady Grove Adventist Hospital, Rockville, MD